Literature DB >> 22126381

Nodal follicular lymphoma without complete follicular dendritic cell networks is related to localized clinical stage.

Wei Cui1, Lisha Che, Yasuharu Sato, Xingang Huang, Katsuyoshi Takata, Yorihisa Orita, Naoe Goto, Yoshinobu Maeda, Mitsune Tanimoto, Tadashi Yoshino.   

Abstract

Follicular lymphoma is the most common low-grade lymphoma and it frequently presents with a systemic disease, often showing advanced clinical stage (III/IV). The lymphoma cells are usually growing associated with follicular dendritic cell (FDC) networks. Abnormal FDC networks have been reported in duodenal follicular lymphoma, in which cases exhibit lower clinical stages than the nodal cases. In the present study, we analyzed the FDC network distribution pattern of 242 nodal follicular lymphomas by immunohistochemistry. Out of the 242 cases, 27 cases (11%) demonstrated an atypical pattern of FDC networks, in which the CD21 staining totally or partially disappeared in the neoplastic follicles. Furthermore, we compared the clinical data of these 27 cases and 58 typical FDC network cases of follicular lymphoma. We found that in the typical cases, 52 out of 58 patients (90%) showed advanced clinical stage (III or IV), whereas 10 of 27 (37%) atypical FDC network cases showed localized clinical stage (I or II) (P < 0.01). In conclusion, nodal follicular lymphoma with total loss or partially disrupted FDC networks therefore show a lower clinical stage.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126381     DOI: 10.1111/j.1440-1827.2011.02736.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Differential expression of estrogen receptor-α on follicular dendritic cells from patients with grade 1-2 and grade 3 follicular lymphoma.

Authors:  Rintaro Ohe; Hong-Xue Meng; Naing Ye Aung; Akane Yamada; Takanobu Kabasawa; Aya Utsunomiya; Nobuyuki Tamazawa; Yuka Tamura; Takumi Kitaoka; Toshio Hashimoto; Kenichi Shibata; Tomomi Toubai; Wataru Kimura; Kenichi Ishizawa; Mitsunori Yamakawa
Journal:  Hematol Oncol       Date:  2019-03-20       Impact factor: 5.271

Review 2.  Follicular dendritic cell sarcoma.

Authors:  Fabio Facchetti; Matteo Simbeni; Luisa Lorenzi
Journal:  Pathologica       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.